HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity.

Abstract
α-synuclein (α-syn) is a main component of Lewy bodies (LB) that occur in many neurodegenerative diseases, including Parkinson's disease (PD), dementia with LB (DLB) and multi-system atrophy. α-syn mutations or amplifications are responsible for a subset of autosomal dominant familial PD cases, and overexpression causes neurodegeneration and motor disturbances in animals. To investigate mechanisms for α-syn accumulation and toxicity, we studied a mouse model of lysosomal enzyme cathepsin D (CD) deficiency, and found extensive accumulation of endogenous α-syn in neurons without overabundance of α-syn mRNA. In addition to impaired macroautophagy, CD deficiency reduced proteasome activity, suggesting an essential role for lysosomal CD function in regulating multiple proteolytic pathways that are important for α-syn metabolism. Conversely, CD overexpression reduces α-syn aggregation and is neuroprotective against α-syn overexpression-induced cell death in vitro. In a C. elegans model, CD deficiency exacerbates α-syn accumulation while its overexpression is protective against α-syn-induced dopaminergic neurodegeneration. Mutated CD with diminished enzymatic activity or overexpression of cathepsins B (CB) or L (CL) is not protective in the worm model, indicating a unique requirement for enzymatically active CD. Our data identify a conserved CD function in α-syn degradation and identify CD as a novel target for LB disease therapeutics.
AuthorsLiyan Qiao, Shusei Hamamichi, Kim A Caldwell, Guy A Caldwell, Talene A Yacoubian, Scott Wilson, Zuo-Lei Xie, Lisa D Speake, Rachael Parks, Donna Crabtree, Qiuli Liang, Stephen Crimmins, Lonnie Schneider, Yasuo Uchiyama, Takeshi Iwatsubo, Yi Zhou, Lisheng Peng, YouMing Lu, David G Standaert, Ken C Walls, John J Shacka, Kevin A Roth, Jianhua Zhang
JournalMolecular brain (Mol Brain) Vol. 1 Pg. 17 (Nov 21 2008) ISSN: 1756-6606 [Electronic] England
PMID19021916 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Neuroprotective Agents
  • RNA, Messenger
  • alpha-Synuclein
  • Caspase 3
  • Cathepsin D
  • Ctsd protein, mouse
  • Proteasome Endopeptidase Complex
Topics
  • Animals
  • Caenorhabditis elegans (drug effects)
  • Caspase 3 (metabolism)
  • Cathepsin D (deficiency, metabolism)
  • Cell Line, Tumor
  • Humans
  • Lysosomes (drug effects, enzymology)
  • Mice
  • Mice, Inbred C57BL
  • Neurons (drug effects, metabolism)
  • Neuroprotective Agents (metabolism)
  • Phagosomes (drug effects, metabolism)
  • Point Mutation (genetics)
  • Proteasome Endopeptidase Complex (metabolism)
  • Protein Structure, Quaternary
  • RNA, Messenger (genetics, metabolism)
  • Up-Regulation (drug effects, genetics)
  • alpha-Synuclein (genetics, metabolism, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: